Jaypirca Tablet, Coated
Product Images NDC 0002-6902

5 FDA label images from Eli Lilly And Company · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Jaypirca (NDC 0002-6902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Jaypirca Uspi Chem Str V1)

Chemical Structure (Jaypirca Uspi Chem Str V1)
Chemical structure diagram of pirtobrutinib, showing molecular features including trifluoromethyl, amine, amide, methoxy, and fluorophenyl groups in the compound.*
FDA Label Image

Figure 1 (Jaypirca Uspi F1 V1)

Figure 1 (Jaypirca Uspi F1 V1)
A Kaplan-Meier curve chart depicting Progression-Free Survival Probability over time since randomization in months. Two treatment groups are compared: JAYPIRCA and IR or BR, with survival probabilities shown on the vertical axis and time in months on the horizontal axis. The chart includes markers for censored data and a risk table showing patient numbers at various time points.*
FDA Label Image

Figure 2 (Jaypirca Uspi F2 V1)

Figure 2 (Jaypirca Uspi F2 V1)
A Kaplan-Meier survival curve comparing progression-free survival probability (%) over time since randomization (months) for JAYPIRCA and BR. The graph shows that JAYPIRCA has a higher progression-free survival rate across approximately 40 months. Censoring marks and the number at risk table for both groups are included below the graph.*
FDA Label Image

Package Label – Jaypirca 50 mg Tablets, 30 Count Bottle (Jaypirca 50mg Bottle 076 03)

Package Label – Jaypirca 50 mg Tablets, 30 Count Bottle (Jaypirca 50mg Bottle 076 03)
Label for Jaypirca 50 mg coated tablets (pirtobrutinib) by Eli Lilly and Company. The label indicates 30 tablets per package and states each tablet contains 50 mg of pirtobrutinib. Storage instructions and handling precautions are included along with the manufacturer's details and a barcode.*
FDA Label Image

Package Label – Jaypirca 100 mg Tablets, 30 Count Bottle (Jaypirca 100mg Bottle 074 03)

Package Label – Jaypirca 100 mg Tablets, 30 Count Bottle (Jaypirca 100mg Bottle 074 03)
Label for Jaypirca (pirtobrutinib) coated tablets, 100 mg strength, in a package containing 60 tablets. The label includes dosage information, storage instructions, the Eli Lilly and Company logo, and mentions the product is marketed by Lilly USA LLC in Indianapolis, IN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.